Rare diseases
Investigational molecules
Locations
A Study Comparing Two Forms of Ocrelizumab Given Under the Skin in Patients with Multiple Sclerosis
ItalyStudy of tuvusertib combined with niraparib or lartesertib for patients with ovarian cancer that worsened after previous PARP inhibitor treatment
ItalyA study testing NNC0194-0499, cagrilintide, and semaglutide alone or combined to treat liver damage in people with alcohol-related liver disease
ItalyItalyA study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin
ItalyA study testing tozorakimab for long-term treatment of chronic obstructive pulmonary disease in former smokers with repeated flare-ups
ItalyLong-term study of sotatercept added to standard treatment in patients with pulmonary arterial hypertension
ItalyA study looking at the safety of switching from emicizumab to denecimig in adults and adolescents with haemophilia A with or without inhibitors
ItalyStudy of BNT111 and cemiplimab in patients with advanced melanoma who have not responded to other therapies
ItalyA Study of Lifileucel with Cyclophosphamide, Fludarabine, and Aldesleukin for Adults with Previously Treated Advanced Melanoma
ItalyA Study of Disitamab Vedotin for Adults with HER2 Expressing Advanced Breast Cancer
ItalyA Study of GSK4524101 and Niraparib for Adults with Advanced Solid Tumors or Metastatic Breast Cancer with BRCA Gene Changes
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
